CXCL8 and CXCR2 tumor expression is related to glioma grade, disease-free survival, and OS in GBM [56], and their upregulation in high-grade glioma correlates with resistance to anti-angiogenic therapy [57,58]. The gene discussed is CXCR2; the disease is neoplasm.